Skip to main content
. 2014 Mar 7;15:69. doi: 10.1186/1471-2474-15-69

Table 2.

Patients’ data of prothesis

Case Age (year)/gender Ennecking’s stage Specimen length (cm) Local recurrence (months) Pulmonary metastasis (months) Revisions (number, months) MSTS score (%) Follow-up time (months)
1
 29/M
 Stage IIB
 8.0
 No
 No
 Aspetic loosening (1,68)
 66
 Alive, 120
2
 37/M
 Stage IIA
 9.5
 No
 No
 Aspetic loosening (1,89)
 73
 Alive, 112
3
 26/F
 Stage IIB
 12.5
 No
 No
 Aspetic loosening (1,76)
 67
 Alive, 105
4
 18/M
 Stage IIB
 13.0
 No
 Conservative (20)
 ---
 65
 Death, 27
5
 24/M
 Stage IIB
 13.5
 No
 No
 ---
 65
 Death, 76
6
 41/F
 Stage IIA
 10.3
 No
 No
 Aspetic loosening (1,73)
 71
 Alive, 82
7
 36/M
 Stage IIA
 11.5
 Amputation (16)
 No
 ---
 56
 Death, 41
8
 20/M
 Stage IIB
 12.5
 No
 No
 Aspetic loosening (1,66)
 67
 Alive, 75
9
 32/M
 Stage IIB
 12.8
 No
 Conservative (25)
 ---
 60
 Death, 34
10
 28/F
 Stage IIA
 10.5
 No
 No
 Aspetic loosening (1,61)
 62
 Death, 69
11
 31/F
 Stage IIB
 8.5
 No
 No
 ---
 67
 Alive, 60
12
 25/F
 Stage IIB
 10.5
 No
 No
 Aspetic loosening (1,50)
 61
 Alive, 57
13
 38/M
 Stage IIB
 10.0
 Amputation (23)
 No
 ---
 51
 Alive, 55
14
 26/F
 Stage IIA
 9.5
 No
 No
 ---
 58
 Alive, 50
15
 32/F
 Stage IIA
 11.0
 No
 No
 ---
 63
 Alive, 48
16
 27/F
 Stage IIB
 9.5
 No
 Conservative (19)
 ---
 72
 Death, 26
17
 31/M
 Stage IIB
 12.5
 No
 No
 Aspetic loosening (1,43)
 63
 Alive, 47
18
 38/M
 Stage IIA
 11.0
 No
 No
 ---
 64
 Alive, 45
19
 29/F
 Stage IIA
 11.5
 No
 No
 ---
 56
 Alive, 41
20
 31/F
 Stage IIA
 9.5
 No
 Conservative (32)
 ---
 67
 Death, 35
21
 23/M
 Stage IIB
 10.2
 No
 No
 Aspetic loosening (1,31)
 62
 Alive, 39
22
 39/M
 Stage IIB
 11.3
 No
 No
 ---
 67
 Alive, 36
23
 27/F
 Stage IIB
 10.0
 Amputation (19)
 No
 ---
 53
 Death, 32
24
 25/M
 Stage IIA
 12.5
 No
 No
 ---
 70
 Alive, 35
25 28/F Stage IIA 13.0 No No --- 64 Alive, 30